Binding of teicoplanin and vancomycin to polymer surfaces

Area of Science:

• Biomaterials Science
• Infectious Diseases
• Pharmaceutical Science

Background:

• Glycopeptide antibiotics, including teicoplanin and vancomycin, are crucial in treating bacterial infections.
• The interaction of these antibiotics with medical device surfaces is not fully understood.
• Understanding antibiotic-surface interactions is vital for optimizing medical device efficacy and preventing infections.

Purpose of the Study:

• To investigate the binding characteristics of teicoplanin and vancomycin to various polymer surfaces.
• To assess the impact of physiological conditions (body fluids, surface charge) on antibiotic binding.
• To evaluate the effect of antibiotic-coated surfaces on Staphylococcus epidermidis adhesion.

Main Methods:

• Quantifying teicoplanin and vancomycin binding to different polymer types using surface analysis techniques.
• Exposing polymer surfaces to human body fluids and altering surface charge to observe binding changes.
• Assessing bacterial (Staphylococcus epidermidis) accumulation on antibiotic-pre-exposed catheter segments in different media.

Main Results:

• Teicoplanin exhibited significantly higher binding to polymer surfaces compared to vancomycin, especially on siliconized polymers.
• Pre-exposure to human body fluids reduced teicoplanin binding by 60%.
• Altering surface charge increased teicoplanin binding tenfold, while bacterial adhesion varied based on antibiotic, surface, and medium (PBS vs. human serum).

Conclusions:

• The binding of teicoplanin and vancomycin to polymer surfaces can influence in-vitro assay results.
• This antibiotic-surface binding phenomenon holds potential for preventing bacterial colonization on medical devices.
• Further research is warranted to leverage these interactions for improved medical device-associated infection control.